Related Experiment Video
Updated: Jul 18, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
Instrumental treatments for benign prostatic obstruction
1Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Minimally invasive treatments for benign prostatic obstruction show promise. Holmium laser enucleation is safe for complex cases, while photoselective vaporization and bipolar TURP offer efficiency and safety, though long-term data is pending.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Benign Prostatic Hyperplasia Management
Background:
- Increasing prevalence of symptomatic benign prostatic obstruction necessitates advanced treatment options.
- Development of minimally invasive instrumental procedures is ongoing.
- Focus on complications and morbidity of current treatments is crucial.
Purpose of the Study:
- To review current research on complications and morbidity of instrumental treatments for symptomatic benign prostatic obstruction.
- To provide an overview of novel and modified minimally invasive procedures.
Main Methods:
- Systematic Medline database search.
- Focused on literature from the past 12 months.
- Included articles on surgical treatment for benign prostatic obstruction/benign prostatic hyperplasia.
Main Results:
- Holmium laser enucleation of the prostate (HoLEP) demonstrates a favorable safety profile, especially for patients with comorbidities.
- Photoselective vaporization of the prostate (PVP) is efficient and safe, but requires further long-term randomized controlled studies.
- Bipolar transurethral resection of the prostate (B-TURP) offers improved hemostasis and avoids transurethral resection syndrome, pending further comparative studies.
Conclusions:
- HoLEP is a safe option for complex benign prostatic obstruction cases.
- PVP shows promise but needs more long-term validation.
- B-TURP presents advantages in hemostasis and safety, requiring more randomized comparisons.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Urinary Tract Calculi VI: Surgical Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antihypertensive Drugs: Vasodilators
